Cause-specific late mortality among 5-year survivors of childhood cancer: the Childhood Cancer Survivor Study.
By A. Mertens, Qi Liu, J. Neglia, K. Wasilewski, W. Leisenring, G. Armstrong, Leslie L. Robison, Y. Yasui. Journal of the National Cancer Institute, 2008
694 citations recorded by the source corpus.
Subfields: Oncology, Pediatrics, Perinatology and Child Health, Public Health, Environmental and Occupational Health
View Paper: https://www.semanticscholar.org/paper/8596e5aa7dd4304b3f5c48fad46742b4040294e7
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Pediatrics, Perinatology and Child Health
In Public Health, Environmental and Occupational Health
Citations in the corpus
- Anthracycline Chemotherapy and Cardiotoxicity (2017, neutral): “05%) after 30 years’ survivorship [76].”
- Cardiotoxicity of anthracycline agents for the treatment of cancer: Systematic review and meta-analysis of randomised controlled trials (2010, background): “Although paediatric malignancies are rare, the high cure rates achieved over the last two decades has highlighted the problems which may be encountered in adult life with relation to treatment induced late effects [2-4].”
- Late mortality among 5-year survivors of childhood cancer: a summary from the Childhood Cancer Survivor Study. (2009, methodology): “Details of methods used for calculation of mortality rates, SMRs, and survival functions have been previously reported.(6,8) In addition to calculation of all-cause SMRs, cause-specific SMRs were calculated by excluding deaths attributable to recurrence or progression of the primary malignancy.”